Translating regenerative medicine science into clinical practice: the local to global pivot
journal contributionposted on 2018-07-16, 08:13 authored by Rich Harrison, Aileen Gracias, William Mitchell
Research into cell and gene therapies is globally dispersed, which creates scientific opportunities, but in turn, significant commercial challenges. In order to successfully bring promising scientific endeavors through to commercial opportunity, greater cross-border coordination of supply side activity considerations such as academic institutions, funding gaps, intellectual property, and commercial entities as well as demand-side issues of reimbursement, regulatory policy, stakeholder engagement and patient engagement should be advocated for.
This study was supported by an EPSRC ETERM Landscape fellowship grant (RH) [grant number EP/I017801/1].
- Aeronautical, Automotive, Chemical and Materials Engineering
- Chemical Engineering
Published inCell & Gene Therapy Insights
Pages469 - 483
CitationHARRISON, R., GRACIAS, A. and MITCHELL, W., 2018. Translating regenerative medicine science into clinical practice: the local to global pivot. Cell & Gene Therapy Insights, 4 (5), pp.469-483
- VoR (Version of Record)
Publisher statementThis work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
NotesThis is an Open Access Article. It is published by Bioinsights under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence (CC BY-NC-ND). Full details of this licence are available at: http://creativecommons.org/licenses/by-nc-nd/4.0/